But even today, more than three decades after BPC-157 was first synthesized, a grand total of three human studies have been conducted, and none of them were the kind of large-scale human trial thats typically part of the traditional drug-approval process
Schwenk RW, Baumeier C, Finan B et al (2015) GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice
ABSTRACT Oxidative stress, involved in many diseases, is defined as an impaired balance between reactive oxygen species (ROS) production and antioxidant defences
Two scenarios could change this: First, if performance-enhancement concerns emerged in specific sports (weight-class sports, endurance sports), WADA or sport-specific bodies could add GLP-1 receptor agonists to prohibited lists
However, evening injections work fine too